Alcon, LENSAR terminate merger agreement after US FTC opposition
Alcon and LENSAR, the two most significant players in the market for laser systems used in femtosecond laser-assisted cataract surgery, said they have agreed to abandon their $365 million merger in...To view the full article, register now.
Already a subscriber? Click here to view full article